About | Free Trial

Last Update

2015-10-13T00:00:00.000Z

This profile was last updated on // .

Is this you? Claim your profile.

Wrong Michael Haude?

Dr. Michael Haude

Chief of Cardiology

Lukaskrankenhaus

Lukaskrankenhaus

Background Information

Employment History

Director of Medical Clinic I
Lukaskrankenhaus

Professor of Internal Medicine
Lukaskrankenhaus

Chief of Cardiology
Stadtische Kliniken Neuss

Professor

Affiliations

Board Member
EuroPCR

Board Member
Medizinische Klinik I

Education

M.D.

MD

Web References (48 Total References)


"The results of BIOSOLVE-II confirm that ...

www.biotronik.com [cached]

"The results of BIOSOLVE-II confirm that the BIOTRONIK Magnesium Scaffold is both a safe and effective option for treating coronary artery disease (CAD), and establish it as the first clinically-proven magnesium-based bioresorbable scaffold," commented principal investigator of the study Dr. Michael Haude of the Lukaskrankenhaus, Neuss, Germany.

...
It is based on a natural element widely present in the human body, and the magnesium-based properties promote a faster and simpler implantation procedure," commented Dr. Haude.


This analysis takes the next step ...

www.cardiacdimensions.com [cached]

This analysis takes the next step in projecting that these benefits result in the cost effectiveness of the therapy," said Michael Haude, M.D. PhD, Chief of Cardiology at Lukaskrankenhaus in Neuss, Germany and co-author of the study.


"Late stent thrombosis is still a ...

www.prnewswire.com [cached]

"Late stent thrombosis is still a concern for patients treated with monotherapy DES, leaving them dependent on a minimum of six months DAPT," said Michael Haude , M.D., director of Medical Clinic I at the Lukaskrankenhaus in Neuss, Germany, and principal investigator of the REMEDEE trial.


The dual therapy stent was shown ...

www.epgonline.org [cached]

The dual therapy stent was shown to be safe and effective, as well as non-inferior to the paclitaxel-eluting stent, according to lead researcher Michael Haude, Professor of Internal Medicine at Lukaskrankenhaus Neuss in Germany. Results of the REMEDEE trial were presented at the Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Visit Cardiology page.


europcr.com - Board Members

www.europcr.com [cached]

Michael Haude

Similar Profiles

Other People with this Name

Other people with the name Haude

Shay Haude
Austin Dental

Cyndi Haude
Klein Independent School District

Daniel Haude
Reminger Co

Lisa Haude
Paradigm Design Group LLC

Erica Haude
Tabor College

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory